InvestorsHub Logo
Followers 7
Posts 810
Boards Moderated 0
Alias Born 03/13/2005

Re: PhenixBleu post# 44369

Saturday, 02/29/2020 1:58:39 PM

Saturday, February 29, 2020 1:58:39 PM

Post# of 50023
If you read all the DEs all the information you want to know is in them.

Attorney fees are limited to $2.5m in recovery.

We already know from the Deposition of Rontan’s tax expert that the tax liabilities were over 750m (Brazilian). $114m USD at the time the SPA was signed. The tax liabilities were for 2015 and prior years according to Rontan’s own witness.

We know from the SPA that the agreed purchase price was $100m plus some earn out credit that would be paid over a period of time.

If you just use the facts. As these are all undisputed facts.

$100m purchase price less $2.5m in litigation fees less $114m in unpaid taxes. This alone still leaves the defendants owing $16.5m which would be offset in subsequent earn out payments.

These are the FACTS of the case. Not pie in the sky pumping on message boards by people unrelated to the company.

The value of the award would be north of $100m, using the undisputed FACTS already established.

I have read every PR since early 2015. Bill Delgado has done everything he promised after running Sullivan et al out.

Converted Toxic financing to non toxic non-dilutive.

Stated that it would require additional financing going forward which he has secured without the use of “toxic” financing.

Cleared all civil complaints and litigations as of 10/2019. Cleared all SEC complaints and actions as of early 2019.

Completed the acquisition of HA in early 2019 and development of PALS continues.

I read no PRs or filings where the company at any time has made any claims to the value of Rontan or the litigation. I’m sure they will in a very short time when the court has made its final ruling and award.


GLTA.

Have a wonderful weekend.